Except for 3 pseudogenes (GUCY1B2, HNRNPA1P33, and TUBA3FP), all of the remaining 15 genes showed the most involvement as tumor suppressor genes in distinct carcinomas, and four genes (TUBGCP2, PLEC, CLEC11A, and BARD1) were associated with AML. This evidence concerns the gene TUBGCP2 and carcinoma.